Search
"People don’t consider that there will be a life after diagnosis"
Latest news, posted 1 March 2023
Beverley has been a Macular Society counsellor for more than 20 years. In this time she has spoken to hundreds of people struggling to come to terms with the life-changing diagnosis of macular disease.
Help abolish VAT on audiobooks
Latest news, posted 1 March 2023
An MP is leading a call in Parliament to abolish VAT on audiobooks, to support people with visual impairments.
Do you suffer from pain after your eye injection?
Latest news, posted 3 April 2023
While many people don’t experience any problems from their regular eye injections, there are a few others who have complained about pain or discomfort in the hours following the treatment.
Workforce Census illustrates severe shortage of eye doctors
Latest news, posted 31 March 2023
The Macular Society has reacted with concern to The Royal College of Ophthalmologist’s 2022 Workforce Census, which reveals the shortage of eye doctors in the UK and the extent of pressure on NHS ophthalmology services.
“I wanted to do something to challenge myself”
Latest news, posted 31 March 2023
A grandmother of four with age-related macular degeneration (AMD) will be taking on her first-ever marathon this month, at the age of 70.
Cyfrifiad y Gweithlu yn dangos prinder difrifol o feddygon llygad
Latest news, posted 31 March 2023
Mae'r Gymdeithas Facwlaidd wedi ymateb gyda phryder i Gyfrifiad y Gweithlu 2022 gan Goleg Brenhinol yr Offthalmolegwyr, sy'n datgelu prinder o feddygon llygad yn y DU a maint y pwysau sydd ar wasanaethau offthalmoleg y GIG.
Changes to voting affecting blind and partially sighted people
Latest news, posted 3 April 2023
The local elections next month will be the first time people across the country will be asked to provide photo ID in order to vote.
New drug for dry AMD - Syfovre: your questions answered
Latest news, posted 4 April 2023
In February we shared the exciting news that the first-ever drug to treat dry age-related macular degeneration (AMD) has been approved in the US. With the support of Apellis Pharmaceuticals, which has brought the drug to market, we answer some of your most frequently asked questions.
‘Inspirational’ Ann, 99, sets out to complete marathon walking challenge
Latest news, posted 5 April 2023
An inspirational 99-year-old is celebrating her milestone year by walking the equivalent distance of a marathon around her local running track in a bid to help beat macular disease.
Treatment delays – “It’s vitally important to speak out”
Latest news, posted 5 April 2023
Stories of delays to vital treatment for age-related macular degeneration (AMD) have been hitting the headlines over the last few weeks. While the news is concerning for many people affected, Pam, who was diagnosed with wet AMD in 2021, has shared why she has spoken out about her own experiences to the national press and why she would encourage others to do the same.